аЯрЁБс>ўџ *ўџџџўџџџ+џџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџ l ЩсСПРт\pThe Free Software Foundation Bфœ=PF0*8X@"Зк1Д Helvetica1ДCourier1Д Courier New1ДМ Courier New1Д Helvetica$#,##0_);($#,##0)$#,##0_);[Red]($#,##0)$#,##0.00_);($#,##0.00)$#,##0.00_);[Red]($#,##0.00)-**_($* #,##0_);_($* (#,##0);_($* "-"_);_(@_)*)'_(* #,##0_);_(* (#,##0);_(* "-"_);_(@_)5,2_($* #,##0.00_);_($* (#,##0.00);_($* "-"??_);_(@_)2+/_(* #,##0.00_);_(* (#,##0.00);_(* "-"??_);_(@_)2$#,##0.00;[Red]$#,##0.003$#,##0.00;[Red]($#,##0.00)4$#,##0;[Red]($#,##00)50.00%;[Red](0.00%)6 0%;[Red](0%)7#,##0.00;[Red](#,##0.00)8#,##0;[Red](#,##0)рѕџ Р рѕџ єР рѕџ єР рѕџ єР рѕџ єР рѕџ єР рѕџ єР рѕџ єР рѕџ єР рѕџ єР рѕџ єР рѕџ єР рѕџ єР рѕџ єР рѕџ єР р Р р+ѕџ јР р)ѕџ јР р,ѕџ јР р*ѕџ јР р ѕџ јР р аˆ ~~Пр иˆ ~~Пр#иˆ ~~Пр иˆ ~~Пр7#мˆ ~~Пр8#мˆ ~~П“€џ“€џ“€џ“€џ“€џ“€џ’т8џџџџџџџџџџџџ€€€€€€€€€РРР€€€™™џ™3fџџЬЬџџffџ€€fЬЬЬџ€џџџџџџ€€€€€џЬџЬџџЬџЬџџ™™Ьџџ™ЬЬ™џџЬ™3fџ3ЬЬ™ЬџЬџ™џfff™–––3f3™f333™3™3f33™ЧЧЧ…&SECURITIES EXCHANGE ACT OF 1934…#SECURITIES EXCHANGE ACT (1)…#x)SECURITIES EXCHANGE ACT (2)…#Ќ:SECURITIES EXCHANGE ACT (3)…&ІKCurrent Ownership of Derivative l Щ 4sq  dќЉёвMbP?_*+‚€%џРŒ,Сƒ„&Тй­e2й?'Тй­e2й?(Тй­e2й?)Тй­e2й?Ё",D/р?р?фSECURITIES EXCHANGE ACT (1)SECURITIES EXCHANGE ACT (2)SECURITIES EXCHANGE ACT (3)!Current Ownership of DerivativeU } $} $ } $} $ } ч 4ссссссссс с с с с сссссссссссссссссссTherapeuticsMD, Inc.SC 13D/A 02/14/2018'SECURITIES EXCHANGE ACT OF 1934CUSIP No. 88338N 10 7Page 2 of 11 Pages    ~ " Name of Reporting Persons.    Robert J. Smith~  0 (Check the Appropriate Box if a Member of (a) ?a Group (b) ?~  SEC Use Only~ Source of FundsPF ? Personal Funds~ 0(Check if Disclosure of Legal Proceedings ?2*is Required Pursuant to Items 2(d) or 2(e)~ ,$Citizenship or Place of Organization United StatesNumber of Shares~ Sole Voting PowerBeneficially Owned~ іby Each Reporting~ "Shared Voting Power Person With -0-~ &Sole Dispositive Power~ і~ * Shared Dispositive PowerзD lрџЬџЖџЊџџsџgџ[џџоўЊў’ўkўўш§Т§Ж§§u§J§ћќ­ќoќWќ2ќыћГћiћ7ћяњ с!с"с#с$с%с&с'с(с)с*с+с,с-с.с/с0с1с2с3с    -0-~ !..!&Aggregate Amount Beneficially Owned by""Each Reporting Person#~ #і~ $21$)Check if the Aggregate Amount in Row (11)%%Excludes Certain Shares& &?~ '6.'&Percent of Class Represented by Amount(( of Row (11)))* *5.87%~ +: +Type of Reporting Person,,- -IN...../0$1____________________________12)Created by Morningstar Document Research.03(http://documentresearch.morningstar.com/з,Ж|Эџџ`џFџџдўЛў{ўXў@ў#ўё§й§П§ƒ§w§k§C§=PF0*8X> Ж@х:'332211--++**((''&&%%$$##""!!     l Щ 7ѓ!С'  dќЉёвMbP?_*+‚€%џРŒ,Сƒ„&Тй­e2й?'Тй­e2й?(Тй­e2й?)Тй­e2й?Ё",D/р?р?ф!SECURITIES EXCHANGE ACT OF 1934SECURITIES EXCHANGE ACT (2)SECURITIES EXCHANGE ACT (3)!Current Ownership of DerivativeU } $} $ } $} $ } ч 7ссссссссс с с с с сссссссссссссссссссTherapeuticsMD, Inc.SC 13D/A 02/14/2018'SECURITIES EXCHANGE ACT OF 1934CUSIP No. 88338N 10 7Page 3 of 11 Pages    ~ " Name of Reporting Persons.   3 +Energy Capital, LLC, an entity solely owned  by Robert J. Smith~  0(Check the Appropriate Box if a Member of (a) ?a Group (b) ?~  SEC Use Only~ Source of FundsPF ? Personal Funds~ 0(Check if Disclosure of Legal Proceedings ?2*is Required Pursuant to Items 2(d) or 2(e)~ ,$Citizenship or Place of Organization United StatesNumber of Shares~ Sole Voting PowerBeneficially Owned~ ђ9&by Each Reporting~ "Shared Voting Power Person With -0-~ &Sole Dispositive PowerзDяlрџЬџЖџЊџџsџgџ[џџоўЊў’ўOў%ўв§Ђ§Š§d§L§#§ §рќ‘ќCќќэћШћћIћџњ с!с"с#с$с%с&с'с(с)с*с+с,с-с.с/с0с1с2с3с4с5с6с   ~ ђ9&!!~ !* !Shared Dispositive Power""" "-0-~ #..#&Aggregate Amount Beneficially Owned by$$Each Reporting Person%%&~ &ђ9&~ '21')Check if the Aggregate Amount in Row (11)((Excludes Certain Shares) )?~ *6.*&Percent of Class Represented by Amount++ of Row (11),,- -0.29%~ .: .Type of Reporting Person//0 0OO1111123$4____________________________15)Created by Morningstar Document Research.06(http://documentresearch.morningstar.com/з2†ИЮџ„џQџџфўЬўВўoў@ў'ўч§Ф§Ќ§§]§E§+§яќуќзќЏќ=PF0*8X> Ж@хB(66554400..--++**))((''&&$$##""!!     l Щ 6o3ї8  dќЉёвMbP?_*+‚€%џРŒ,Сƒ„&Тй­e2й?'Тй­e2й?(Тй­e2й?)Тй­e2й?Ё",D/р?р?ф!SECURITIES EXCHANGE ACT OF 1934SECURITIES EXCHANGE ACT (1)SECURITIES EXCHANGE ACT (3)!Current Ownership of DerivativeU } $} $ } $} $ } ч 6ссссссссс с с с с сссссссссссссссссссTherapeuticsMD, Inc.SC 13D/A 02/14/2018'SECURITIES EXCHANGE ACT OF 1934CUSIP No. 88338N 10 7Page 4 of 11 Pages    ~ " Name of Reporting Persons.   1 )Plato & Associates, LLC, an entity solely  owned by Robert J. Smith~  0(Check the Appropriate Box if a Member of (a) ?a Group (b) ?~  SEC Use Only~ Source of FundsPF ? Personal Funds~ 0(Check if Disclosure of Legal Proceedings ?2*is Required Pursuant to Items 2(d) or 2(e)~ ,$Citizenship or Place of Organization United StatesNumber of Shares~ Sole Voting PowerBeneficially Owned~ 2>›by Each Reporting~ "Shared Voting Power Person With -0-~ &Sole Dispositive Power~ 2>›зD lрџЬџЖџЊџџsџgџ[џџоўЊў’ўQў!ўЮ§ž§x§`§7§§єќЅќWќќќмћ•ћ]ћћсњ с!с"с#с$с%с&с'с(с)с*с+с,с-с.с/с0с1с2с3с4с5с  ~ * Shared Dispositive Power!!! !-0-~ ".."&Aggregate Amount Beneficially Owned by##Each Reporting Person$$%~ %2>›~ &21&)Check if the Aggregate Amount in Row (11)''Excludes Certain Shares( (?~ )6.)&Percent of Class Represented by Amount** of Row (11)++, ,4.95%~ -: -Type of Reporting Person../ /OO0000012$3____________________________14)Created by Morningstar Document Research.05(http://documentresearch.morningstar.com/з0@ЄЖџƒџCџџўўфўЁўrўYўўі§о§С§§w§]§!§§ §сќ=PF0*8X> Ж@хB(554433//--,,**))((''&&%%##""!!     l Щ 5—DѓI  dќЉёвMbP?_*+‚€%џРŒ,Сƒ„&Тй­e2й?'Тй­e2й?(Тй­e2й?)Тй­e2й?Ё",D/р?р?ф!SECURITIES EXCHANGE ACT OF 1934SECURITIES EXCHANGE ACT (1)SECURITIES EXCHANGE ACT (2)!Current Ownership of DerivativeU } $} $ } $} $ } ч 5ссссссссс с с с с сссссссссссссссссссTherapeuticsMD, Inc.SC 13D/A 02/14/2018'SECURITIES EXCHANGE ACT OF 1934CUSIP No. 88338N 10 7Page 5 of 11 Pages    ~ " Name of Reporting Persons.   5 -Jo Cee, LLC, an entity solely owned by Robert  J. Smith~  0(Check the Appropriate Box if a Member of (a) ?a Group (b) ?~  SEC Use Only~ Source of FundsPF ? Personal Funds~ 0(Check if Disclosure of Legal Proceedings ?2*is Required Pursuant to Items 2(d) or 2(e)~ ,$Citizenship or Place of Organization United StatesNumber of Shares~ Sole Voting PowerBeneficially Owned~ Ђb9by Each Reporting~ "Shared Voting Power Person With -0-~ &Sole Dispositive Power~ Ђb9зDlрџЬџЖџЊџџsџgџ[џџоўЊў’ўMў-ўк§Њ§„§l§C§+§§Бќcќ%ќ ќшћЁћiћћэњ с!с"с#с$с%с&с'с(с)с*с+с,с-с.с/с0с1с2с3с4с  ~ * Shared Dispositive Power!!! !-0-~ ".."&Aggregate Amount Beneficially Owned by##Each Reporting Person$~ $Ђb9~ %21%)Check if the Aggregate Amount in Row (11)&&Excludes Certain Shares' '?~ (6.(&Percent of Class Represented by Amount)) of Row (11)**+ +0.43%~ ,: ,Type of Reporting Person--. .OO/////01$2____________________________13)Created by Morningstar Document Research.04(http://documentresearch.morningstar.com/з.ЖџƒџCџџќўЙўŠўqў1ўўі§й§Ї§§u§9§-§!§љќ=PF0*8X> Ж@хB(443322..,,++))((''&&%%$$##""!!     l Щ ‡R  dќЉёвMbP?_*+‚€%џРŒ,Сƒ„&Тй­e2й?'Тй­e2й?(Тй­e2й?)Тй­e2й?Ё",D/р?р?ф!SECURITIES EXCHANGE ACT OF 1934SECURITIES EXCHANGE ACT (1)SECURITIES EXCHANGE ACT (2)SECURITIES EXCHANGE ACT (3)U } } } ѓ2 ссссссссс с с с с сссссссTherapeuticsMD, Inc.SC 13D/A 02/14/20182*Current Ownership of Derivative Securities Exhibit No.Date of DocumentDescription of Document~ * 06/19/12# Note Purchase Agreement (1) 333333$@ 06/19/12 Security Agreement (1) ffffff$@ 06/19/12, $Secured Promissory Note, form of (1) š™™™™™$@ 06/19/122 *Common Stock Purchase Warrant, form of (1) ЭЬЬЬЬЬ$@ 09/26/12) !Securities Purchase Agreement (2)%@01/31/13Revolving Line Note (3)$____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/з,|рџЬџЖџЊџtџhџ\џPџњўБўiўўЗ§d§§§§лќ=PF0*8X> Ж@х Root Entryџџџџџџџџ РFўџџџBook џџџџџџџџџџџџ S  !"#$%&'()ўџџџўџџџ§џџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџџ